Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > ONC sponsoring Cgy Flames post game radio

<< Previous

Bullboard Posts

Next >>

Comment by 13X2413on Nov 01, 2023 9:06pm

126 Views

Post# 35712552

RE:RE:RE:RE:RE:RE:RE:ONC sponsoring Cgy Flames post game radio

Noteable, It took awhile, but finally some negativity from you. Now you can start to be as p*ssed off as some of us are. I'm not just talking about the posters on this forum, I'm also including the sellers that took this down to this $2 level.

<< Previous

Bullboard Posts

Next >>

POET increases production capacity to meet AI demand